BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7479450)

  • 21. Active immunization in HIV-infected patients.
    Pau AK; McNicholl IR; Pursell KJ
    Pharmacotherapy; 1996; 16(2):163-70. PubMed ID: 8820461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):901-6. PubMed ID: 8927012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine immunization in HIV: helpful or harmful?
    Sax P; Singer M
    AIDS Clin Care; 1996 Feb; 8(2):11-3, 15. PubMed ID: 11363059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on universal childhood immunizations.
    Hamlin J; Senthilnathan S; Bernstein HH
    Curr Opin Pediatr; 2008 Aug; 20(4):483-9. PubMed ID: 18622208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Meningitis caused by Haemophilus influenzae type b: its immunological prevention. A necessity?].
    Fernandez J
    Arch Domin Pediatr; 1994; 30(1):21-4. PubMed ID: 12290026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(8):144-8. PubMed ID: 8309463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
    Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients--12 western states, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Oct; 46(39):919-23. PubMed ID: 9347905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview and horizons in prevention of some human infectious diseases by vaccination.
    Sabin AB
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):114-27. PubMed ID: 210652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age- and cause-specific childhood mortality in Lombok, Indonesia, as a factor for determining the appropriateness of introducing Haemophilus influenzae type b and pneumococcal vaccines.
    Nelson CM; Sutanto A; Gessner BD; Suradana IG; Steinhoff MC; Arjoso S
    J Health Popul Nutr; 2000 Dec; 18(3):131-8. PubMed ID: 11262765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain.
    Díez-Domingo J; Pereiró I; Morant A; Gimeno C; San-Martín M; González A;
    J Infect; 2001 May; 42(4):257-60. PubMed ID: 11545568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of immunization on Haemophilus influenzae type b disease.
    Madore DV
    Infect Agents Dis; 1996 Jan; 5(1):8-20. PubMed ID: 8789595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis].
    Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR
    Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
    Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L;
    Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Romero A; Lopez G; Dal-Ré R
    Pediatrics; 2005 Dec; 116(6):1292-8. PubMed ID: 16322149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pneumococcal vaccination for persons 65 years of age and older].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines for persons at high risk, 2007.
    Zimmerman RK; Middleton DB
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S38-46, C4-5. PubMed ID: 17270109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.